IS5385A - Statin-LP (A) inhibitor preparations for liposuction - Google Patents

Statin-LP (A) inhibitor preparations for liposuction

Info

Publication number
IS5385A
IS5385A IS5385A IS5385A IS5385A IS 5385 A IS5385 A IS 5385A IS 5385 A IS5385 A IS 5385A IS 5385 A IS5385 A IS 5385A IS 5385 A IS5385 A IS 5385A
Authority
IS
Iceland
Prior art keywords
liposuction
statin
inhibitor preparations
preparations
inhibitor
Prior art date
Application number
IS5385A
Other languages
Icelandic (is)
Inventor
Larry Bisgaier Charles
Schofield Newton Roger
Ranjee Ramharack Randy
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of IS5385A publication Critical patent/IS5385A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IS5385A 1997-12-12 2000-02-25 Statin-LP (A) inhibitor preparations for liposuction IS5385A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6943297P 1997-12-12 1997-12-12
PCT/US1998/023480 WO1999030706A1 (en) 1997-12-12 1998-11-04 ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS

Publications (1)

Publication Number Publication Date
IS5385A true IS5385A (en) 2000-02-25

Family

ID=22088939

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5385A IS5385A (en) 1997-12-12 2000-02-25 Statin-LP (A) inhibitor preparations for liposuction

Country Status (14)

Country Link
EP (1) EP1037623A1 (en)
JP (1) JP2003524582A (en)
KR (1) KR20010033017A (en)
AU (2) AU1306099A (en)
BR (1) BR9813539A (en)
CA (1) CA2299397A1 (en)
HU (1) HUP0100349A3 (en)
IL (1) IL134364A0 (en)
IS (1) IS5385A (en)
NO (1) NO20002965L (en)
NZ (1) NZ502874A (en)
PL (1) PL343851A1 (en)
WO (1) WO1999030706A1 (en)
ZA (1) ZA9811349B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956026B2 (en) 1997-01-07 2005-10-18 Amylin Pharmaceuticals, Inc. Use of exendins for the reduction of food intake
EP1076091A1 (en) * 1999-08-09 2001-02-14 Universite Catholique De Louvain Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds
US20030036504A1 (en) * 2000-01-10 2003-02-20 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
EP1275388A4 (en) * 2000-02-10 2003-11-26 Takeda Chemical Industries Ltd Tnf- alpha inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2016467A1 (en) * 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
WO1993013801A1 (en) * 1992-01-17 1993-07-22 The Procter & Gamble Company Treatment for atherosclerosis
WO1993016690A1 (en) * 1992-02-25 1993-09-02 Warner-Lambert Company Cytoprotective compositions containing pyruvate and antioxidants
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
EP0738510A3 (en) * 1995-04-20 2005-12-21 L'oreal Use of a HMG-CoA reductase inhibitor as an anti-ageing agent and as an anti-acne agent. Composition comprising at least one HMG-CoA reductase inhibitor and at least one active substance with scaling properties.
JP2000508659A (en) * 1996-04-17 2000-07-11 メルク エンド カンパニー インコーポレーテッド Combination therapy to reduce cardiovascular disease-related risks
NZ503982A (en) * 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
PL343851A1 (en) 2001-09-10
NO20002965D0 (en) 2000-06-09
NO20002965L (en) 2000-06-09
BR9813539A (en) 2000-10-10
JP2003524582A (en) 2003-08-19
IL134364A0 (en) 2001-04-30
AU1306099A (en) 1999-07-05
AU2003244047A1 (en) 2003-09-25
WO1999030706A1 (en) 1999-06-24
EP1037623A1 (en) 2000-09-27
CA2299397A1 (en) 1999-06-24
HUP0100349A2 (en) 2001-07-30
NZ502874A (en) 2004-03-26
HUP0100349A3 (en) 2002-02-28
KR20010033017A (en) 2001-04-25
ZA9811349B (en) 1999-06-14

Similar Documents

Publication Publication Date Title
NO995433D0 (en) Protease inhibitors
DK0921796T3 (en) Tetrahydrolipstatin-containing preparations
LU91426I2 (en) Fosamprenavir calcium - TELZIR
NO20006717D0 (en) protease inhibitors
DK1004669T3 (en) Newly differentiated inhibitor
DE69807508T2 (en) POSITIONING
ID18995A (en) AMIDA-AMIDA INHIBITOR APO B-SECRETION / MTP
IS5354A (en) New compounds
DK1027332T3 (en) New lactametalloprotease inhibitors
DK0958287T3 (en) Sulfamidmetalloprotease inhibitors
NO996578D0 (en) Urokinase inhibitors
DE59910159D1 (en) Radiation-curable preparations
NO995434D0 (en) protease inhibitors
NO995435D0 (en) Protease inhibitors
NO995268D0 (en) protease inhibitors
DE69818559D1 (en) strapping
IS5385A (en) Statin-LP (A) inhibitor preparations for liposuction
DE69803763D1 (en) SANDERS
DK0905025T3 (en) strapping
DE59812470D1 (en) positioning
NO995005L (en) A new approach
DE59804807D1 (en) PI COMPLEX COMPOUNDS
ID21138A (en) FILM-THIN TECHNOLOGY FOR HEAD-DRUM
FI3336U1 (en) Card application generated for continuation form
EE04114B1 (en) HIV protease inhibitors